At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PDX PIMCO DYNAMIC INCOME STRATEGY FUND
Not Yet Opened 10-21 16:00:00 EDT
20.30
-0.10
-0.49%
盘后20.30
+0.000.00%
19:30 EDT
High20.59Low20.27Vol79.43K
Open20.43D1 Closing20.40Amplitude1.59%
Mkt Cap907.55MTradable Cap907.55MTotal Shares44.71M
T/O1.62MT/O Rate0.18%Tradable Shares44.71M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Saba Capital Management Reports Sale of $43,070.50 in Pimco Dynamic Income Strategy Fund Common Shares
Reuters  ·  10-16
Saba Capital Management Reports Sale of $43,070.50 in Pimco Dynamic Income Strategy Fund Common Shares
Saba Capital Management Disposes of $239,193 Pimco Dynamic Income Strategy Fund Shares
Reuters  ·  10-08
Saba Capital Management Disposes of $239,193 Pimco Dynamic Income Strategy Fund Shares
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Dow Jones  ·  10-02
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results
GlobeNewswire  ·  09-29
Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results
Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer
GlobeNewswire  ·  09-25
Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer
Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015
GlobeNewswire  ·  09-22
Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015
Saba Capital Management Sells 19,692 Pimco Dynamic Income Strategy Fund Shares for $406,836.72
Reuters  ·  09-17
Saba Capital Management Sells 19,692 Pimco Dynamic Income Strategy Fund Shares for $406,836.72
Saba Capital Reports $474,452 Pimco Dynamic Income Strategy Fund Common Share Sale
Reuters  ·  09-14
Saba Capital Reports $474,452 Pimco Dynamic Income Strategy Fund Common Share Sale
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Dow Jones  ·  09-02
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Dow Jones  ·  08-31
Press Release: BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
GlobeNewswire  ·  08-27
Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit
Pimco Portfolio Manager Greg Elliot Sharenow Buys $131,030 of Pimco Dynamic Income Strategy Fund Common Shares
Reuters  ·  08-21
Pimco Portfolio Manager Greg Elliot Sharenow Buys $131,030 of Pimco Dynamic Income Strategy Fund Common Shares
Saba Capital Management Disposes of $291,530 Pimco Dynamic Income Strategy Fund Shares
Reuters  ·  08-19
Saba Capital Management Disposes of $291,530 Pimco Dynamic Income Strategy Fund Shares
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
GlobeNewswire  ·  08-12
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
PIMCO Executive Committee Member Thibault Christian Stracke Acquires PIMCO Dynamic Income Strategy Fund Common Shares Worth $540,468‬
Reuters  ·  08-11
PIMCO Executive Committee Member Thibault Christian Stracke Acquires PIMCO Dynamic Income Strategy Fund Common Shares Worth $540,468‬
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
GlobeNewswire  ·  08-06
Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Dow Jones  ·  08-04
Press Release: PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Pimco Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement for Assistant Treasurer Paul Vitale
Reuters  ·  07-09
Pimco Dynamic Income Strategy Fund Files Initial Beneficial Ownership Statement for Assistant Treasurer Paul Vitale
Press Release: PIMCO Closed-end Funds Declare Monthly Common Share Distributions
Dow Jones  ·  07-02
Press Release: PIMCO Closed-end Funds Declare Monthly Common Share Distributions
Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
Dow Jones  ·  05-27
Press Release: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update

Introduction

Company Name.
PIMCO DYNAMIC INCOME STRATEGY FUND
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Issue price:
--